Brazil Authorizes Oxford / AstraZeneca and Coronavac Vaccines for Emergency Use


Minutes later, Monica Calajan, a black nurse from the city of São Paulo, became the first Brazilian to be vaccinated. Calazans, who is at high risk for Kovid-19 complications and works in an ICU that has a 90% capacity or above since April, exploded in tears before receiving a Coronavac shot.

“You don’t understand what this means for me,” he told São Paulo State Governor João Doria.

Brazil is the country hardest hit by Kovid-19 in Latin America. It has recorded more than 8 million cases and more than 200,000 deaths from coronaviruses. While many of its neighbors have already approved vaccines for use, Brazil has lagged behind despite its renowned public health and vaccination track record.

Coronavac, developed by the Chinese company Synovac, is now authorized to use 6 million imported supplements. It has a history in the state of São Paulo, where the local Butanan Institute conducted clinical trials of the third phase of the vaccine. Butanon will also produce future supplements.

However, Coronavac has shown a low average efficacy rate of 50.4% – less than the minimum established by the World Health Organization. This number, which is well below the previously announced 78%, casts doubt on the veracity of the data and the apparent lack of transparency about Chinese vaccines.

The technical report of the ANVISA Greenlighting Coronavac stressed that the agency also took into account the urgency and “absence of therapeutic options” of Brazil’s Skywatering Covid-19 cases.

Here's how some of the major coronavirus vaccines work

It also recommended that the vaccine be further monitored, with the Butanon Institute not providing critical data from its Phase III study, such as the duration of protection provided by the vaccine and its effect on the elderly, comradeship, and other patients. With groups.

Doria has promised to make in-state developed vaccines available to the Brazilian Federal Ministry of Health for national distribution.
“Today is V day. It is the day of vaccine, it is the day of truth, it is the day of victory, it is the day of life,” he said after approving the vaccines in a press conference – A. Health Minister Eduardo Pazuelo’s reluctance to have a start date for the nationwide vaccination, which he previously said “will start in D Day and Hour H.”
The Oxford / AstraZeneca vaccine, which showed a 70.4% average efficacy in early phase III trials, has also been approved for the use of 2 million doses, which will be imported from the Serum Institute of India by the Oswaldena Cruz Foundation of Brazil (FiroCruz).

In June, Fiocruz signed an agreement with drug giant AstraZeneca to purchase and produce the vaccine. After a gradual delay, the Brazilian government signed a contract for 256 million doses in October and announced that it would receive the first in December.

After another series of delays, FiroCruz hopes to receive the first shipment by the end of January.

CNN’s Rodrigo Pedroso from Sao Paulo and Katlin Hu from New York reported.

.

Leave a Reply

Your email address will not be published.